AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

RIVASTIGMINE

18 registrations across 2 African markets— 2 active

Markets with RIVASTIGMINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
VITACHOLINE 1.5
Gélule / 1.5 mg
🇹🇳TunisiaTAHA PHARMAexpiredJun 2019
VITACHOLINE 3
Gélule / 3 mg
🇹🇳TunisiaTAHA PHARMAexpiredJun 2019
VITACHOLINE 4.5
Gélule / 4.5 mg
🇹🇳TunisiaTAHA PHARMAexpiredJun 2019
VITACHOLINE 6
Gélule / 6 mg
🇹🇳TunisiaTAHA PHARMAexpiredJun 2019
RIVETAL
Gélule / 6 mg
🇹🇳TunisiaGENEPHARM S.AexpiredJun 2017
RIVETAL
Gélule / 3 mg
🇹🇳TunisiaGENEPHARM S.AexpiredMar 2017
RIVETAL
Gélule / 1.5 mg
🇹🇳TunisiaGENEPHARM S.AexpiredMar 2017
RIVETAL
Gélule / 4.5 mg
🇹🇳TunisiaGENEPHARM S.AexpiredMar 2017
RIVAXEL
Solution buvable / 2 mg/ml
🇹🇳TunisiaADWYAexpiredFeb 2017
VITACHOLINE 3
Gélule / 3 mg
🇹🇳TunisiaTAHA PHARMAexpiredFeb 2017
VITACHOLINE 1.5
Gélule / 1.5 mg
🇹🇳TunisiaTAHA PHARMAexpiredFeb 2017
VITACHOLINE 4.5
Gélule / 4.5 mg
🇹🇳TunisiaTAHA PHARMAexpiredFeb 2017
VITACHOLINE 6
Gélule / 6 mg
🇹🇳TunisiaTAHA PHARMAexpiredFeb 2017
EXELON PATCH 5
Dispositif trans-dermique / 4.6 mg/24 H
🇹🇳TunisiaNOVARTIS PHARMA SCHWEIZ AGexpiredJun 2011
EXELON PATCH 10
Dispositif trans-dermique / 9.5 mg/24 H
🇹🇳TunisiaNOVARTIS PHARMA SCHWEIZ AGexpiredJun 2011
EXELON PATCH 10
Dispositif trans-dermique / 9.5 mg/24 H
🇹🇳TunisiaNOVARTIS PHARMA SCHWEIZ AGexpiredJun 2011
EXELON PATCH 5
DISPOSITIF TRANSDERMIQUE
🇲🇦Moroccoactive
EXELON PATCH 10
DISPOSITIF TRANSDERMIQUE
🇲🇦Moroccoactive

RIVASTIGMINE in Africa — Regulatory Overview

RIVASTIGMINE is registered across 2 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 18 registrations, 2 (11%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.